Related Experiment Video
Updated: May 26, 2026

08:52
Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells
Published on: June 13, 2018
Diseases in a dish: modeling human genetic disorders using induced pluripotent cells
Gustavo Tiscornia1, Erica Lorenzo Vivas, Juan Carlos Izpisúa Belmonte
1Centre of Regenerative Medicine in Barcelona, Barcelona, Spain.
Nature Medicine
|December 8, 2011
Summary
Induced pluripotent stem cells (iPSCs) from genetic syndromes enable disease research and therapeutic development. This review covers key considerations for modeling genetic diseases with iPSCs.
Area of Science:
- Stem cell biology
- Genetics
- Disease modeling
Background:
- Induced pluripotent stem cells (iPSCs) offer a powerful tool for studying genetic diseases.
- Deriving iPSCs from patients with genetic syndromes provides a unique disease-specific model.
- These cells possess self-renewal and differentiation capabilities, crucial for research.
Purpose of the Study:
- To review the conceptual and practical aspects of using iPSCs for genetic disease modeling.
- To highlight the potential of iPSCs in advancing basic research and therapeutic development for genetic disorders.
- To discuss challenges and considerations in establishing robust iPSC-based disease models.
Main Methods:
- Review of existing literature on iPSC derivation and application in genetic disease research.
- Analysis of conceptual frameworks for disease modeling using patient-derived iPSCs.
- Discussion of practical challenges, including iPSC generation, characterization, and differentiation protocols.
Main Results:
- iPSCs provide a renewable and patient-specific source for studying genetic disease mechanisms.
- Successful modeling of various genetic syndromes using iPSCs has been demonstrated.
- The potential for drug screening and personalized medicine approaches is significant.
Conclusions:
- iPSC technology presents a transformative approach to understanding and treating genetic diseases.
- Careful consideration of conceptual and practical issues is essential for effective iPSC-based disease modeling.
- Further research is needed to optimize protocols and fully realize the therapeutic potential of iPSCs.
More Related Videos
Related Concept Videos
EPS and iPS Cells in Disease Research
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Somatic cells are...
iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

